BXC
BlueLinx Holdings Inc.
BXC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has the edge over BXC overall, supported by lower modeled downside and stronger fundamentals.
BXC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
BXC's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BXC PE Valuation
BXC has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BXC Forward outlook
There aren't enough analyst estimates for BXC to show an outlook.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BXC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.49 | -128% |
| Q2 2026 | -$0.22 | -106% |
| Q1 2026 | -$0.49 | -111% |
| Q4 2025 | $0.02 | -100% |
| Q3 2025 | $1.74 | -51% |
| Q2 2025 | $3.41 | -22% |
| Q1 2025 | $4.52 | -17% |
| Q4 2024 | $6.19 | +15% |
BXC has swung to a loss: it lost $0.49 per share over the past year, after a profit the year before.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over BXC on earnings quality, reporting a profit while its opponent remains loss making.
BXC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $812.6M | +8.5% |
| Q2 2026 | $814.1M | +4.4% |
| Q1 2026 | $731.1M | +3.1% |
| Q4 2025 | $715.8M | +0.7% |
| Q3 2025 | $748.9M | +0.2% |
| Q2 2025 | $780.1M | +1.5% |
| Q1 2025 | $709.2M | -2.3% |
| Q4 2024 | $710.6M | -0.3% |
BXC's revenue is recovering but still below its 2021 peak: $813M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +0.1 points |
| Q2 2026 | 2.5% | +0.6 points |
| Q1 2026 | 1% | -0.5 points |
| Q4 2025 | -0.5% | -2.1 points |
| Q3 2025 | 1.3% | -1.9 points |
| Q2 2025 | 1.9% | -1.2 points |
| Q1 2025 | 1.5% | -2.3 points |
| Q4 2024 | 1.7% | -2.1 points |
BXC's operating margin was 1.5% last quarter, about level with the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BXC on profitability, with a higher operating margin.
BXC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $39.6M | -25% |
| Q2 2026 | $8.8M | +$45.2M |
| Q1 2026 | -$59.8M | -$20M |
| Q4 2025 | $56.4M | +$57.9M |
| Q3 2025 | $52.7M | -2.2% |
| Q2 2025 | -$36.4M | -224% |
| Q1 2025 | -$39.8M | -$3.3M |
| Q4 2024 | -$1.5M | -102% |
BXC's free cash flow has turned positive again: $45M over the past year, against −$25M the year before.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over BXC on cash flow, with more consistent year-over-year improvement.
BXC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +2.8K shares |
| 1 year | -1.1% | -84.2K shares |
| 3 years | -12% | -1.1M shares |
| 5 years | -21% | -2.1M shares |
| Available history | -16% | -1.5M shares |
BXC has 8M diluted shares, down 1.1% from a year ago, with $5M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.6M |
| Q1 2026 | $2.8M |
| Q4 2025 | — |
| Q3 2025 | $2.7M |
| Q2 2025 | $20.4M |
| Q1 2025 | $15M |
| Q4 2024 | $15.3M |
BXC spent $5M buying back its own shares over the past year, down 90% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over BXC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BXC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -1.4x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
BXC has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BXC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.2 | Neutral |
| Stochastic | 28.4 | Neutral |
BXC's weekly RSI is 45 (neutral) and its Stochastic is 28 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BXC PE vs Industrials Sector
| Metric | BXC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BXC has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BXC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.7 | 12% below |
| 20 week MA | $71.7 | 12% below |
| 50 week MA | $64.9 | 3.1% below |
| 100 week MA | $71.8 | 13% below |
| 200 week MA | $84.7 | 26% below |
BXC is in a downtrend: it's below all five of its weekly moving averages, and 26% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BXC on trend strength, trading above more of its moving averages.
BXC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.2 | $29.4 | +123% |
| 2021 | $29.4 | $87.1 | +197% |
| 2022 | $87.1 | $72.0 | -17% |
| 2023 | $72.0 | $113.3 | +57% |
| 2024 | $113.3 | $103.7 | -8.5% |
| 2025 | $103.7 | $62.6 | -40% |
| 2026 YTD | $62.6 | $62.8 | +0.4% |
BXC has finished lower in three of the last six years. It's roughly flat so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BXC on returns for 2026, with the stronger performance.